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Abstract
Aims/hypothesis The aim of this study was to examine
whether waist circumference (WC) or WHR improve
diabetes prediction beyond body mass index in older men
and women, and to define optimal cut-off points.
Methods In this prospective study, non-diabetic men (n=
3,519) and women (n=3,404) aged 60–79 years were
followed up for 7 years. There were 169 and 128 incident
cases of type 2 diabetes in men and women, respectively.
Results BMI, WC and WHR all showed strong associations
with incident type 2 diabetes independent of potential
confounders. In men, the adjusted relative risks (top vs
lowest quartile) were 4.71 (95% CI 2.45–9.03) for BMI,
3.53 (95% CI 1.92–6.48) for WC and 2.76 (95% CI 1.58–
4.82) for WHR. For women, the corresponding relative
risks were 4.10 (95% CI 2.16–7.79), 12.18 (95% CI 4.83–
30.74) and 5.61 (95% CI 2.84–11.09) for BMI, WC and
WHR, respectively. Receiver-operating characteristic curve
analysis revealed similar associations for BMI and WC in
predicting diabetes in men (AUC=0.726 and 0.713,
respectively); WHR was the weakest predictor (AUC=
0.656). In women, WC was a significantly stronger
predictor (AUC=0.780) than either BMI (AUC=0.733) or
WHR (AUC=0.728; p<0.01 for both). Inclusion of both
WC and BMI did not improve prediction beyond BMI
alone in men or WC alone in women. Optimal sensitivity
and specificity for the prediction of type 2 diabetes was
observed at a WC of 100 cm in men and 92 cm in women.
Conclusions/interpretation In older men, BMI and WC
yielded similar prediction of risk of type 2 diabetes, whereas
WC was clearly a superior predictor in older women.
Keywords Abdominal adiposity . Bodymass index . Type 2
diabetes .Waist circumference .Waist-to-hip ratio
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Introduction
Obesity is an important risk factor for type 2 diabetes. The
strong association between abdominal fat and increased risk
of cardio-metabolic risk [1] suggests that measures of
central fat distribution such as waist circumference (WC)
and WHR may be better than measures of general obesity,
such as BMI, in predicting type 2 diabetes. This may be
particularly important in the elderly population in whom
BMI is known to be a weaker indicator of obesity because
visceral fat increases and muscle mass declines with age
[2]. The National Heart Lung and Blood Institute recom-
mends the use of WC as an additional means of assessing
the risks associated with excessive adiposity [3]. Although
several prospective studies have shown WC to be a better
predictor of diabetes than BMI [4–8], the results are
inconclusive [9–13]. Indeed, in a recent meta-analysis
based on 32 studies, BMI, WC and WHR were all shown
to have similar associations with risk of incident type 2
diabetes, suggesting that all measures are important in
predicting the risk of diabetes [14]. However, this meta-
analysis did not stratify analyses by sex, which may be a
potentially important omission. Furthermore, few studies
have compared the use of these anthropometric markers in
older individuals and determined whether the use of BMI
combined with measures of body fat distribution (WC or
WHR) improves the ability to predict diabetes. This is an
important clinical question as the greatest relative increase
in type 2 diabetes prevalence in developed countries in the
next 25 years will be in those aged over 65 years [15].
Uncertainties also remain about the best combination of
anthropometric measures to use in men and women and the
optimal cut-off points, particularly in older people.
We have examined the predictive power of BMI, WC
and WHR in predicting incident diabetes and evaluated WC
cut-off points to assess diabetes risk in a prospective study
of men and women aged 60–79 years. We have also
examined the combined use of BMI and measures of fat
distribution (WC and WHR) in predicting type 2 diabetes.
Methods
Data from the British Regional Heart Study and the British
Women’s Heart and Health Study were used. The British
Regional Heart Study is a prospective study of cardiovas-
cular disease involving 7,735 British men drawn from
general practices in 24 British towns and cities who were
followed up from 1978 to 1980 [16, 17]. In 1998–2000, all
surviving men, now aged 60–79 years, were invited for a
20th year follow-up examination; 4,252 men (77% of
survivors) attended for examination. In 1999–2001, a
parallel study of 4,286 women (60% of those invited) of
the same age and drawn from 22 of the same 24 towns and
cities was established, with the addition of one more study
city (Bristol) [18]. Full details of the selection of partic-
ipants and measurements have been reported previously
[18]. The study population was predominantly (>95%)
described as white by examining nurses.
Similar protocols for data collection were used in both
studies. In both studies, nurses administered questionnaires,
made physical measurements and collected fasting venous
blood samples, from which serum was stored at −70°C for
subsequent analysis. Men and women completed detailed
questionnaires on: medical history; medication; and life-
style, including cigarette smoking, alcohol consumption
and physical activity. Details of measurement and classifi-
cation methods for smoking status, physical activity, social
class, blood pressure and blood lipids in the two cohorts
have been described elsewhere [18–21]. All participants
provided written informed consent to the investigation and
ethical approval was provided by all relevant local research
ethics committees. Fasting glucose measurements were
available in 3829 women (89%) and 4032 men (95%).
We excluded all men and women with prevalent diabetes
(defined as the presence of a diagnosis by a doctor of
diabetes and/or a fasting glucose of ≥7 mmol/l) (n=481
men, n=377 women) and four women whose diabetes
status could not be determined. We further excluded those
with missing BMI, waist and hip measurements (n=32
men; n=44 women). After these exclusions, a total of 3519
non-diabetic men and 3404 non-diabetic women were
eligible for the current study.
Anthropometric measurements Measurements included
height, weight and waist and hip circumferences. Partic-
ipants were measured standing in light clothing without
shoes. Height was measured with a Holtain (Crosswell, UK)
stadiometer to the last complete 0.1 cm and weight was
measured with a Soehnle (Waagen, Murrhardt, Germany)
digital electronic scale to the last complete 0.1 kg. Body mass
index (weight/height2 in kg/m2) was calculated for each
individual. Waist and hip circumferences were measured in
duplicate with an insertion tape (CMS, London, UK); hip
circumference was measured at the point of maximum
circumference over the buttocks. The waist measurement
was taken from the midpoint between the iliac crest and the
lower ribs measured at the sides. WHR was calculated as
WC divided by hip circumference.
Follow-up All men and women were followed up for all-
cause mortality, cardiovascular morbidity and development
of type 2 diabetes. Losses to follow-up remained excep-
tionally low (<3%) in both cohorts. The analysis is based
on follow-up from re-screening (1998–2000) to June 2006
in men and from 1999–2001 to September 2007 in women,
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a mean follow-up period of 7 years (6–8 years). Informa-
tion on deaths has been collected through the established
‘tagging’ procedures provided by the National Health
Service central registers. Information on the incidence of
new events has been obtained from the combination of
regular two yearly reviews of patients’ notes (including
hospital and clinic correspondence) through to the end of
the study period and from personal questionnaires to
surviving participants, repeated since the initial examina-
tion, asking whether a doctor had ever told them that they
had diabetes, the year of diagnosis and reported use of
medications specifically for diabetes. Self-report of doctor-
diagnosed diabetes has shown to be a valid measure of
recording diabetes in the present study [22]. The medical-
record reviewwas comparedwith the patient's recall of doctor-
diagnosed diabetes. In 97% of men who reported a doctor
diagnosis of diabetes on the questionnaire, the diagnosis was
confirmed on review of the records. Because of the high
agreement, self-report of diabetes has been included.
Statistical analysis The study population was stratified into
sex-specific quartiles of BMI, WC and WHR. A Cox
proportional hazards model was used to assess age-adjusted
and multivariate-adjusted hazard ratio (HR). Age, systolic
blood pressure, log triacylglycerol and log fasting glucose
were fitted as continuous variables in the multivariate
analysis. Physical activity, smoking, parental history of
diabetes, manual social class, pre-existing CHD and alcohol
intake were fitted as categorical variables. Finally,
receiving-operating characteristic (ROC) curve analyses
and the respective AUC [23] were used to compare the
predictive power of baseline WC, WHR, and BMI on risk
of type 2 diabetes in men and women. All data analyses
were performed with STATA version 10.0.
Results
During follow-up, there were 165 incident cases of type 2
diabetes in the 3,519 men (7.15/1,000 person-years) and
128 cases in the 3,404 women (5.40/1,000 person-years).
BMI correlated most strongly with WC in both men and
women (r=0.87 and r=0.83, respectively) and correlated
more with WHR in men than in women (r=0.53 and r=
0.35). Sex-specific baseline characteristics of the study
sample are shown in Table 1. Men have higher WC and
WHR than women. Mean age, BMI and systolic blood
pressure were similar for men and women. Compared with
the women, men were more physically active and had
higher rates of smoking, consumption of alcohol and pre-
existing CHD, but lower rates of family history of diabetes.
The relationships between WC, WHR and BMI and risk
of type 2 diabetes in men and women are shown in Table 2.
All indicators were strongly and significantly associated
with risk of type 2 diabetes in both men and women after
adjustment for potential confounders including age, social
class, alcohol intake, smoking status, physical activity,
parental history of diabetes and pre-existing CHD. Further
adjustment for systolic blood pressure, HDL-cholesterol
and log plasma glucose reduced the associations, but they
remained significant. In men BMI and WC showed similar
associations; WHR was the weakest predictor. In women
WC was by far the strongest predictor.
The positive association between BMI and the risk of
type 2 diabetes remained strong even after adjustment for
WHR in both men and women (p for trend <0.0001 for
both sexes; Tables 2, 3). In men BMI was a significant
predictor of diabetes after adjustment for age and WC and
remained significant even after additional adjustment for other
potential confounders and possible mediators (p=0.01).
However, in women BMI was not a predictor of diabetes
when adjustments were made for age and WC alone. By
contrast WC remained significantly associated with diabetes
in women in the fully adjusted model that included
adjustment for BMI. In men adjustment for BMI attenuated
the association between WC and diabetes in men and this
association was not significant after adjustment for potential
confounders and mediators. Adjustment for BMI attenuated
the association between WHR and diabetes in men but made
little difference in women.
There was no significant interaction between age or
parental history and adiposity measures with risk of
diabetes and no significant interaction was seen between
WC and BMI and diabetes in men or women (p=0.49 and
p=0.77 for men and women, respectively).
Unadjusted ROC analyses indicate that BMI and WC
were similar in predicting type 2 diabetes in men; WHR
was the weakest (Fig. 1). In men, the AUC was 0.726 for
BMI, 0.713 for WC (p=0.20 for differences in AUC for
WC vs BMI) and AUC=0.656 for WHR. Addition of WC
to BMI did not improve prediction in men (difference in
AUC=0.001 p=0.73). When stratified by BMI levels
(<25 kg/m2, 25–29.9 kg/m2 and 30+kg/m2), WC did not
improve prediction of diabetes in any of the BMI groups. In
women, WC was the best predictor of type 2 diabetes
(AUC=0.780) and was significantly better than BMI (AUC=
0.733, p=0.002) and WHR (AUC=0.728, p=0.005). WC
improved prediction within all BMI groups, particularly
those who were not obese (BMI <30 kg/m2). The addition of
BMI or WHR to WC did not improve prediction in women
(difference in AUC=0.0007, p=0.73 for adding BMI;
difference in AUC=0.008, p=0.63 for adding WHR).
Adjustment for age made little difference to the ROC curves.
We also assessed the improvement of prediction of the
anthropometric measures when age and parental history
were included in the model. In both men and women BMI
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Characteristic Mena (n=3,519) Womenb (n=3,404) p value
Age (years) 68.6 (5.5) 69.3 (5.5) <0.0001
BMI (kg/m2) 26.7 (3.5) 27.3 (4.8) <0.0001
WC (cm) 96.5 (10.0) 85.4 (11.7) <0.0001
Hip circumference (cm) 102.1 (6.9) 104.6 (10.0) <0.0001
WHR 0.94 (0.06) 0.81 (0.07) <0.0001
Inactive, % (n) 32.6 (1109) 63.0 (2065) <0.0001
Current smokers, % (n) 13.0 (455) 11.05 (376) 0.0127
Parental history of diabetes, % (n) 5.5 (195) 9.3 (318) <0.0001
Manual social class, % (n) 50.7 (1784) 48.9 (1518) 0.1439
Systolic blood pressure (mmHg) 148.5 (23.9) 146.2 (24.9) 0.0001
HDL-cholesterol (mmol/l) 1.34 (0.34) 1.67 (0.45) <0.0001
Triacylglycerolc (mmol/l) 1.58 (1.13, 2.15) 1.62 (1.2, 2.16) 0.0549
Glucosec (mmol/l) 5.55 (5.52, 5.91) 5.68 (5.4, 6) <0.0001
Pre-existing CHD, % (n) 10.7 (375) 15.3 (515) <0.0001
Daily and weekend drinking, % (n) 63.6 (2192) 38.89 (1216) <0.0001
Table 1 Baseline characteristics
in men and women with no
prevalent diabetes
Data are mean values (SD)
unless otherwise stated
a Incident cases of diabetes: 165
b Incident cases of diabetes: 128
c Geometric mean (interquartile
range)
Table 2 Age-adjusted and multivariate-adjusted hazard ratios and 95% CI for type 2 diabetes according to quartiles of anthropometric indicators
in men
Variable Cases Rate/1,000
person-years
Age-adjusted Adjusteda Adjustedb Adjustedc Adjustedd
All men 165 7.15
Quartiles
BMI (kg/m2)
<24.38 11 1.94 1.00 1.00 1.00 1.00 1.00
24.38– 22 3.76 1.94 (0.94–4.00) 1.85 (0.89–3.81) 1.72 (0.83–3.57) 1.40 (0.67–2.92) 1.43 (0.68–2.99)
26.42– 38 6.40 3.29 (1.68–6.43) 3.04 (1.55–5.96) 2.21 (1.11–4.39) 1.88 (0.92–3.83) 1.57 (0.77–3.23)
28.71– 94 16.82 8.90 (4.76–16.6) 7.35 (3.90–13.84) 4.71 (2.45–9.03) 3.36 (1.56–7.21) 2.48 (1.14–5.42)
p trend quartiles <0.001 <0.001 <0.001 <0.001 0.014
WC (cm)
<90.1 13 2.23 1.00 1.00 1.00 1.00 1.00
90.1– 27 4.60 2.08 (1.07–4.02) 1.95 (1.00–3.78) 1.52 (0.78–2.97) 1.48 (0.76–2.89) 1.27 (0.65–2.48)
96.5– 40 6.86 3.1 (1.66–5.8) 2.84 (1.52–5.33) 1.93 (1.02–3.65) 1.69 (0.89–3.24) 1.31 (0.68–2.54)
102.5– 85 15.35 7.06 (3.94–12.65) 5.89 (3.26–10.65) 3.53 (1.92–6.48) 2.17 (1.08–4.37) 1.59 (0.77–3.26)
p trend quartiles <0.001 <0.001 <0.001 0.026 0.214
WHR
<0.907 16 2.7 1.00 1.00 1.00 1.00 1.00
0.907– 35 6.00 2.25 (1.25–4.07) 2.03 (1.12–3.69) 1.64 (0.9–2.97) 1.53 (0.84–2.79) 1.26 (0.68–2.3)
0.95– 42 7.23 2.74 (1.54–4.88) 2.41 (1.35–4.32) 1.75 (0.98–3.15) 1.46 (0.81–1.27) 1.20 (0.66–2.19)
0.98– 72 13.13 5.10 (2.97–8.78) 4.38 (2.53–7.59) 2.76 (1.58–4.82) 2.25 (1.27–3.98) 1.65 (0.92–2.95)
p trend quartiles <0.001 <0.001 <0.001 0.03 0.069
a Adjusted for age, smoking, physical activity, alcohol intake, parental history of diabetes and pre-existing CHD
bAdjusted for age, smoking, physical activity, alcohol intake, parental history of diabetes, pre-existing CHD, systolic blood pressure, HDL-C and
log blood glucose
c Adjusted for age and BMI/WC
dAdjusted for age, smoking, physical activity, alcohol intake, parental history of diabetes, pre-existing CHD, systolic blood pressure, HDL-C, log
blood glucose and BMI/WC
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and WC significantly improved prediction of diabetes
beyond age and parental history alone. The AUC for a
model with age and parental history was 0.52 for men. This
increased significantly to 0.73 with the addition of BMI and
0.71 with WC (for all differences in AUC p<0.0001). The
addition of WC made no significant improvement beyond
BMI. For women the AUC for age and parental history was
0.60 and this improved significantly with the addition of
BMI (AUC=0.75) or WC (AUC=0.79; for all differences
in AUC p<0.0001). The addition of WC to the model with
age, parental history and BMI improved the prediction in
women (AUC=0.79, p=0.01).
We also assessed the optimal cut-off points for BMI and
WC for identifying diabetes in men and women. Table 4
shows the sensitivity, specificity and positive predictive
value for the various cut-off points for BMI and WC in men
and women. For women, 92 cm appeared to be the optimal
WC cut-off point in terms of the sum of the sensitivity and
specificity; for men, the optimal cut-off point for WC was
100 cm. For BMI the optimal cut-off point for men was
between 28 and 29 kg/m2 and for women the optimal cut-
off point was between 29 and 30 kg/m2.
Discussion
In this study of older men and women, aged 60–79 years,
both general adiposity (BMI) and the common measures of
regional adiposity (WC and WHR) strongly and indepen-
dently predicted incident diabetes in both men and women
after adjusting for potential confounders and risk factors,
including plasma lipids, plasma glucose and blood pressure.
Our study confirms previous studies showing that both
overall and abdominal adiposity play an important role in
diabetes [4–14] and extends these findings to older adults.
There has been much discussion of which anthropometric
measure best predicts diabetes and the usefulness of WC or
WHR over BMI [14]. Few prospective studies have
examined these issues in older adults. Our study also
provides new information regarding the possible optimal
Table 3 Age-adjusted and multivariate-adjusted hazard ratio and 95% CI for type 2 diabetes according to quartiles of anthropometric indicators in
women
Variable Cases Rate/1,000
person-years
Age-adjusted Adjusteda Adjustedb Adjustedc Adjustedd
All women 128 5.40
Quartiles
BMI (kg/m2)
<24.07 12 2.03 1.00 1.00 1.00 1.00 1.00
24.07– 12 2.01 0.98 (0.44–2.17) 0.99 (0.44–2.20) 0.86 (0.38–1.92) 0.64 (0.29–1.44) 0.64 (0.28–1.44)
26.65– 26 4.35 2.14 (1.08–4.23) 2.01 (1.01–4.00) 1.64 (0.82–3.28) 0.94 (0.46–1.94) 0.92 (0.44–1.91)
29.78– 78 13.3 6.46 (3.52–11.88) 5.80 (3.11–10.81) 4.10 (2.16–7.79) 1.34 (0.61–2.92) 1.27 (0.57–2.82)
p trend quartiles <0.001 <0.001 <0.001 0.162 0.231
WC (cm)
<77.1 5 0.84 1.00 1.00 1.00 1.00 1.00
77.1– 13 2.16 2.60 (0.93–7.28) 2.54 (0.90–7.12) 2.30 (0.81–6.46) 2.40 (0.85–6.76) 2.22 (0.79–6.29)
84.05– 23 3.86 4.68 (1.78–12.3) 4.34 (1.64–11.44) 3.83 (1.44–10.16) 4.00 (1.49–10.77) 3.60 (1.33–9.73)
92.3– 87 15.12 18.34 (7.44–45.16) 16.64 (6.70–41.35) 12.18 (4.83–30.74) 13.68 (5.11–36.66) 10.82 (3.98–29.37)
p trend quartiles <0.001 <0.001 <0.001 <0.001 <0.001
WHR
<0.77 10 1.64 1.00 1.00 1.00 1.00 1.00
0.77– 12 1.99 1.25 (0.54–2.9) 1.24 (0.54–2.88) 1.08 (0.46–2.54) 1.05 (0.45–2.43) 0.95 (0.4–2.24)
0.81– 33 5.61 3.61 (1.78–7.32) 3.29 (1.62–6.69) 2.85 (1.4–5.82) 2.56 (1.25–5.23) 2.3 (1.12–4.74)
0.86– 73 12.83 8.39 (4.33–16.27) 7.36 (3.78–14.36) 5.61 (2.84–11.09) 5.38 (2.75–10.52) 4.25 (2.13–8.47)
p trend quartiles <0.001 <0.001 <0.001 <0.001 <0.001
a Adjusted for age, smoking, physical activity, alcohol intake, parental history of diabetes and pre-existing CHD
bAdjusted for age, smoking, physical activity, alcohol intake, parental history of diabetes, pre-existing CHD, systolic blood pressure, HDL-C and
log blood glucose
c Adjusted for age and BMI/WC
dAdjusted for age, smoking, physical activity, alcohol intake, parental history of diabetes, pre-existing CHD, systolic blood pressure, HDL-C, log
blood glucose and BMI/WC
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range of clinical utility for WC in predicting future diabetes
in older adults. By analysis of ROC curves we have shown
that in men, WC and BMI showed similar associations with
incident diabetes; WHR was the weakest predictor. How-
ever, in women the WC was a significantly better indicator
of diabetes risk than BMI or WHR, and enhanced
prediction of diabetes beyond BMI.
There is no clear consensus on which obesity measure
performs best in predicting diabetes. Previous prospective
studies comparing WC, BMI and WHR for predicting
diabetes risk have been inconsistent [4–13]. Indeed, in a
recent meta-analysis of 32 studies worldwide it was
concluded that these three obesity indicators have similar
associations with incident diabetes [14]. Most of the studies
included were carried out in populations with wide age-
ranges and analyses but, critically, the analyses were not
stratified by sex or age group. Our finding that WC is a
better predictor of diabetes than BMI or WHR in older
women but not in older men is consistent with and extends
data from several other prospective studies. The Iowa
Women’s Health Study of postmenopausal women (aged
55–69 years) showed those in the top quintile of the WC
distribution to be associated with the largest relative risk
compared with the top quintile of BMI and WHR [7]. In the
MONICA/KORA Augsburg Cohort Study, WC emerged as
the stronger predictor of type 2 diabetes in women but in
men BMI appeared to be the stronger predictor, as was seen
in our study [11]. In the Nurses Health Study of women
aged 30–55 years, WC was the strongest predictor of
diabetes when compared with BMI and WHR [8]. In the
Health Professionals Follow-Up Study of men aged 40–
75 years, BMI and WC showed similar associations; WHR
was the weakest predictor [10]. In the EPIC-Potsdam Study
of men and women aged 35–65 years WC was a better
predictor of incident diabetes than BMI among women but
not among men [12]. In the Atherosclerosis Risk in
Communities (ARIC) Study of adults aged 40–64 years,
BMI and WC showed similar associations in men, with
WHR being the weakest predictor [9], in close agreement
with our findings. However, in female ARIC participants all
anthropometric measures showed similar associations with
diabetes risk, in contrast to our findings. Taken together, the
results of these studies and our data suggest that the
measure of obesity that best predicts diabetes may be
dependent on age and sex, and that waist circumference is a
better predictor of diabetes in women.
The measurement of WC is recommended in the US
National Institutes of Health clinical guidelines for the
assessment or management of obesity [3]. However, its
utility in clinical practice has been questioned because of
the training required to ensure that reliable WC data are
collected [1]; other weaknesses, including lack of consen-
sus regarding the best thresholds for defining obesity in
different populations, have been discussed [24]. Of the few
prospective studies which have assessed whether the
combined use of general obesity with measures of body
fat distribution can improve prediction of diabetes, some have
suggested that combined use does not provide additional
information beyond any single measure [9, 13], as was
observed in this study. In older men, there is no evidence that
measurement of WC provides additional clinical information
beyond that provided by BMI, and vice versa in women. The
finding that WC is a far better predictor of diabetes than BMI
in older women lends support to the use of WC in older
women (and perhaps in women in general) to identify those
at high risk of developing diabetes. Further study would be
required, however, before this could be done reliably in
clinical practice.
The cut-off point for WC recommended for use in
clinical practice remains controversial [1]. The ATP III
criteria define ‘abdominally obese’ as WC >88 cm for
women and >102 cm for men. However, in the present
study, ROC curve analysis showed that WC thresholds of
about 92 and 100 cm in women and men, respectively,
provided optimal discrimination for diabetes, at least as
defined in terms of the sum of sensitivity and specificity.
The results suggest that the threshold could be increased in
women. However, for women sensitivity would be sub-
stantially lowered if this method for defining optimal
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Fig. 1 The ROC curves (unadjusted) for BMI, WC and WHR for (a)
men and (b) women. ROC area in men: BMI 0.726; WHR 0.656; WC
0.713. ROC area in women: BMI 0.733; WHR 0.728; WC 0.780
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threshold was applied and a higher threshold of 92 cm was
used. The threshold of 88 cm yielded 76% sensitivity
(specificity 63%) whilst a threshold of 92 cm would yield a
sensitivity of under 70% but a specificity of 75%. By contrast
in men, the results suggest that for diabetes prediction the
current recommended WC guidelines of 102 cm could be
lowered to 100 cm for identifying diabetes risk, supporting the
findings of Wang et al. [10]. By lowering the threshold,
sensitivity is increased though specificity decreases. This
method of calculating optimal cut-points gives equal
weighting to the notion of sensitivity and specificity and
may not be ideal for the assessment of screening thresholds
for diabetes in clinical practice. It is likely that optimal
thresholds will depend on weighing the issues of cost as well
as maximising the identification of those at high risk. We
appreciate the need for replication of our findings in
independent studies before changes to thresholds are made.
Our study is not without some limitation. It was carried
out in an older, predominantly white, European population;
we cannot generalise our findings to younger populations
or to other ethnic groups, in which the relations between
anthropometric measurements and diabetes risk are clearly
different [25]. The determination of diabetes incidence in
this study relied on documented doctor-diagnosed cases of
diabetes, which inevitably results in under ascertainment of
cases. This may also influence the performance of anthro-
pometric measurements as BMI is the more routine marker
measured in clinical practice. However, if anything, WC
Table 4 Sensitivity, specificity and positive predictive value (PPV) and percentage of cases identified using sex-specific cut-off points for BMI
and WC to predict diabetes over 7 years
Variable Men (n=3,519) Women (n=3,404)
n Cases % Sensitivity Specificity PPV (%) n Cases % Sensitivity Specificity PPV (%)
BMI (kg/m2)
≥25 2,382 147 67.7 89.1 33.4 6.2 2270 114 66.7 89.1 34.2 5.0
≥26 1,968 139 55.9 84.2 45.5 7.1 1916 107 56.3 83.6 44.8 5.6
≥27 1,506 123 42.8 74.5 58.8 8.2 1583 99 46.1 77.3 54.7 6.3
≥28 1,107 99 31.5 60.0 69.9 8.9 1290 92 37.9 71.9 63.4 7.1
≥29 799 89 22.7 53.9 78.8 11.1 1024 84 30.1 65.6 71.3 8.2
≥30 519 71 14.7 43.0 86.6 13.7 812 78 23.9 60.9 77.6 9.6
Waist (cm)
≥80 2,189 120 64.3 93.8 36.8 5.5
≥81 2,071 118 60.8 92.2 40.4 5.7
≥82 1,949 116 57.3 90.6 44.0 6.0
≥83 1,833 112 53.9 87.5 47.5 6.1
≥84 1,712 110 50.3 85.9 51.1 6.4
≥85 1,597 109 46.9 85.2 54.6 6.8
≥86 1,494 104 43.9 81.3 57.6 7.0
≥87 1,389 101 40.8 78.9 60.7 7.3
≥88 1,283 98 37.7 76.6 63.8 7.6
≥89 1,174 96 34.5 75.0 67.1 8.2
≥90 1,071 93 31.5 72.7 70.1 8.7
≥91 975 92 28.6 71.9 73.0 9.4
≥92 890 89 26.1 69.5 75.5 10.0
≥93 799 85 23.5 66.4 78.2 10.6
≥94 2,110 138 60.0 83.6 41.2 6.5 723 76 21.2 59.4 80.3 10.5
≥95 1,969 133 55.9 80.6 45.3 6.8 660 74 19.4 57.8 82.1 11.2
≥96 1,826 128 51.9 77.6 49.4 7.0
≥97 1,676 123 47.6 74.5 53.6 7.3
≥98 1,499 119 42.6 72.1 58.8 7.9
≥99 1,335 112 37.9 67.9 63.5 8.4
≥100 1,202 106 34.2 64.2 67.3 8.8
≥101 1,071 99 30.4 60.0 71.0 9.2
≥102 931 91 26.5 55.2 75.0 9.8
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emerges as the far stronger predictor in women and this
argument would bias against WC being a better predictor.
Conversely it might be argued that since markers of central
obesity (WC or WHR) have been shown to be more strongly
associated with CHD risk than BMI in women in several
studies [7, 26], women with higher WC are more likely to
have health problems and more contact with their doctors
and thus are more likely to be diagnosed. To address this
possible bias we examined cross-sectionally the relation-
ship of WC, BMI and hyperglycaemia (fasting glucose
concentration ≥6.2 mmol/l) in non-diabetics. WC was a
significantly stronger predictor of hyperglycaemia than
BMI in women, but in men WC and BMI showed similar
predictive power. These findings suggest ascertainment bias
is unlikely to explain WC being a better predictor of
clinically diagnosed diabetes in women. The stronger
association between WC and fasting blood glucose (a strong
determinant of diabetes) compared with BMI in women may
contribute to explaining why WC is a better predictor of
diabetes than BMI. However, WC remained a significantly
better predictor than BMI after adjustment for fasting blood
glucose. Finally, our study cannot determine whyWC should
be a better predictor of diabetes in elderly women compared
with elderly men, but suggests this as an area for future
investigation.
Conclusion
Both overall and central adiposity indices are strong
predictors of type 2 diabetes in older adults. BMI is as
strong as WC in predicting type 2 diabetes in men. In
women, however, WC was a significantly better measure
for the identification of diabetes risk. The use of BMI
combined with WC does not improve identification of type
2 diabetes risk beyond single measures of BMI (in men) or
WC (in women). Current recommended guidelines for WC
in men of 102 cm could be lowered to identify diabetes
risk, whereas those for older women could be increased.
Finally, future simple diabetes-prediction algorithms could
usefully include WC in those applicable to women, though
for changes to clinical practice one would need to ensure
that better prediction in research settings is not negated by
poorer reliability of the measurement in routine practice.
Acknowledgements The British Regional Heart Study is a British
Heart Foundation (BHF) Research Group and is supported by a BHF
Programme grant. The British Women’s Heart and Health Study is
jointly funded by the UK Department of Health and the BHF. O.
Papacosta is supported by a project grant from Diabetes UK. The
views expressed in this publication are those of the authors and not
necessarily those of the funding bodies.
Duality of interest The authors declare that there is no duality of
interest associated with this manuscript.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Klein S, Allison DB, Heymsfield SB, Association for Weight
Management and Obesity Prevention; NAASO; Obesity Society;
American Society for Nutrition; American Diabetes Association;
Association for Weight Management and Obesity Prevention;
NAASO, the Obesity Society; the American Society for Nutrition;
and the American Diabetes Association et al (2007) Waist
circumference and cardiometabolic risk: a consensus statement
from shaping America’s health. Diabetes Care 30:1647–1652
2. Gallergher D, Visser M, Sepulveda D, Pierson RN, Harris T,
Heymsfield SB (1996) How useful is body mass index for
comparison of body fatness across age, sex and ethnic groups?
Am J Epidemiol 143:228–239
3. National Institutes of Health (1998) Clinical guidelines on the
identification, evaluation and treatment of overweight and obesity
in adults—the evidence report. Obes Res 6:51S–209S
4. Wei M, Gaskill SP, Haffner SM, Stern MP (1997) Waist
circumference as the best predictor of noninsulin dependent
diabetes mellitus (NIDDM) compared to body mass index,
waist/hip ratio and other anthropometric measurements in Mex-
ican Americans—a 7-year prospective study. Obes Res 5:16–23
5. The Diabetes Prevention Program Research Group (2006) The
relationship of body size and shape to the development of diabetes
in the Diabetes Prevention Program. Obesity 14:2107–2117
6. Snijder MB, Dekker JM, Visser M et al (2003) Associations of hip
and thigh circumferences independent of waist circumference with
the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr
77:1192–1197
7. Folsom AR, Kushi LH, Anderson KE et al (2000) Associations of
general and abdominal obesity with multiple health outcomes in
older women: the Iowa Women’s Health Study. Arch Intern Med
160:2117–2128
8. Carey VJ, Walters EE, Colditz GA et al (1997) Body fat
distribution and risk of non-insulin-dependent diabetes mellitus
in women. The Nurses’ Health Study. Am J Epidemiol 145:614–
619
9. Stevens J, Couper D, Pankow J et al (2001) Sensitivity and
specificity of anthropometrics for the prediction of diabetes in a
biracial cohort. Obes Res 9:696–705
10. Wang Y, Rimm EB, Stampfer MJ, Wilett WC, Hu FB (2005)
Comparison of abdominal adiposity and overall obesity in
predicting risk of type 2 diabetes among men. Am J Clin Nutr
81:555–563
11. Meisinger C, Döring A, Thorand B, Heier M, Löwel H (2006)
Body fat distribution and risk of type 2 diabetes in the general
population: are there differences between men and women? The
MONICA/KORA Augsburg Cohort Study. Am J Clin Nutr
84:483–489
12. Schulze MB, Heidemann C, Schienkiewitz A, Bergmann MM,
Hoffmann K, Boeing H (2006) Comparison of anthropometric
characteristics in predicting the incidence of type 2 diabetes in the
EPIC-Potsdam Study. Diabetes Care 29:1921–1923
13. Tulloch-Reid MK, Williams DE, Looker HC, Hanson RL,
Knowler WC (2003) Do measures of body fat distribution provide
information on the risk of type 2 diabetes in addition to measures
of general obesity? Comparison of anthropometric predictors of
type 2 diabetes in Pima Indians. Diabetes Care 26:2556–2561
Diabetologia (2010) 53:890–898 897
14. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K (2007)
Comparison of body mass index, waist circumference, and waist/
hip ratio in predicting incident diabetes: a meta-analysis. Epide-
miol Rev 29:115–128
15. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global
prevalence of diabetes: estimates for the year 2000 and projections
for 2030. Diabetes Care 27:1047–1053
16. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ (1981)
British Regional Heart Study: cardiovascular risk factors in
middle-aged men in 24 towns. BMJ 283:179–186
17. Walker M, Shaper AG, Lennon L, Whincup PH (2000) Twenty
year follow-up of a cohort study based in general practices in 24
British towns. J Publ Health Med 22:479–485
18. Lawlor DA, Bedford C, Taylor M, Ebrahim S (2003) Geograph-
ical variation in cardiovascular disease, risk factors, and their
control in older women: British Women’s Heart and Health Study.
J Epidemiol Community Health 57:134–140
19. Wannamethee SG, Lowe GDO, Whincup PH, Rumley A, Walker
M, Lennon L (2002) Physical activity and hemostatic and
inflammatory variables in elderly men. Circulation 105:1785–
1790
20. Emberson J, Whincup PH, Walker M, Thomas M, Alberti KGMM
(2002) Biochemical measures in a population based study: the effect
of fasting duration and time of day. Ann Clin Biochem 39:493–501
21. Lawlor DA, Sattar N, Davey Smith G, Ebrahim S (2005) The
associations of physical activity and adiposity with alanine
aminotransferase and gamma-glutamyltransferase. Am J Epidemiol
161:1081–1088
22. Perry IJ (1995) Non-insulin-dependent diabetes and coronary
heart disease in middle-aged British men. PhD thesis, University
of London
23. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing
the areas under two or more correlated receiver operating character-
istic curves: a nonparametric approach. Biometrics 44:837–845
24. Han TS, Sattar N, Lean M (2006) ABC of obesity. Assessment of
obesity and its clinical implications. BMJ 333:695–698
25. WHO Expert Consultation (2004) Appropriate body-mass index
for Asian populations and its implications for policy and
intervention strategies. Lancet 363:157–163
26. Yang L, Kuper H, Weiderpass E (2008) Anthropometric character-
istics as predictors of coronary heart disease in women. J Intern
Med 264:39–49
898 Diabetologia (2010) 53:890–898
